Alternatives to ANI Pharmaceuticals

AI-powered platform for designing novel molecular structures for new medicines.

Clinical-stage company developing novel treatments for ocular inflammatory blinding diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A global oncology company developing and commercializing innovative cancer treatments.

Diversified biopharmaceutical company focused on rare diseases and generics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

AI-powered platform accelerating biological research and drug discovery.

Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Leveraging the adaptive immune system to diagnose and treat disease.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-powered platform for understanding disease biology and accelerating drug discovery.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-guided drug discovery platform for tissue-targeted medicines.

Developing engineered biologics to harness the immune system for disease treatment.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Mapping cell-cell communication at scale in human tissue.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

A global pharmaceutical company focused on developing and marketing innovative treatments.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-first company designing novel, functional proteins to revolutionize biomedicine and agriculture.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery and development platform for biologics.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company developing next-generation gene writing tools for advanced therapies.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

Advance every cancer decision.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biotechnology company developing novel immunotherapies for cancer.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.